Transtinib, a potent tyrosine kinase inhibitor inhibits L858R/T790M mutant NSCLC cell lines and xenografts

by Hu, Peng, Han, Da-xiong, Ruan, Run-sheng, Zheng, Li-Mou, Chou, Shiu-Huey, Tzeng, Chi-Meng
Published 2016